200 related articles for article (PubMed ID: 10612485)
1. Cortisol metabolism in the postoperative period after cardiac surgery.
Vogeser M; Felbinger TW; Röll W; Jacob K
Exp Clin Endocrinol Diabetes; 1999; 107(8):539-46. PubMed ID: 10612485
[TBL] [Abstract][Full Text] [Related]
2. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
3. Quantification of cortisol inactivation in cirrhosis of the liver.
Vogeser M; Fischer G; Jacob K
Exp Clin Endocrinol Diabetes; 1998; 106(5):410-4. PubMed ID: 9831307
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
Hoshiro M; Ohno Y; Masaki H; Iwase H; Aoki N
Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
[TBL] [Abstract][Full Text] [Related]
5. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
Finken MJ; Andrews RC; Andrew R; Walker BR
J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
[TBL] [Abstract][Full Text] [Related]
6. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
[TBL] [Abstract][Full Text] [Related]
7. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
[TBL] [Abstract][Full Text] [Related]
8. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
Kerstens MN; Buter H; Navis GJ; Dullaart RP
Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
[TBL] [Abstract][Full Text] [Related]
9. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
10. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
11. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.
Remer T; Maser-Gluth C; Boye KR; Hartmann MF; Heinze E; Wudy SA
Steroids; 2006 Jul; 71(7):591-8. PubMed ID: 16616286
[TBL] [Abstract][Full Text] [Related]
13. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
Stewart PM; Burra P; Shackleton CH; Sheppard MC; Elias E
J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
[TBL] [Abstract][Full Text] [Related]
14. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
Palermo M; Armanini D; Shackleton CH; Sorba G; Cossu M; Roitman E; Scaroni C; Delitala G
Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):272-6. PubMed ID: 12373630
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
16. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
Główka FK; Kosicka K; Karaźniewicz-Łada M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):283-9. PubMed ID: 20018571
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly.
Trainer PJ; Drake WM; Perry LA; Taylor NF; Besser GM; Monson JP
J Clin Endocrinol Metab; 2001 Jul; 86(7):2989-92. PubMed ID: 11443156
[TBL] [Abstract][Full Text] [Related]
18. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
19. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
20. Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics.
Santini DL; Lorenzo BJ; Koufis T; Reidenberg MM
Am J Hypertens; 1995 May; 8(5 Pt 1):516-9. PubMed ID: 7662229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
